Ketoprofen
Formulation
The table below describes the formulation of ketoprofen and the controls morphine sulfate and gabapentin for the following in vivo experiments.
Experiment(s) | Compound | Dose(s) mg/kg | Correction factor | Dose volume mL/kg | Route | Vehicle | Suspension / Solution |
---|---|---|---|---|---|---|---|
Pharmacokinetics | Ketoprofen | 3, 6 | 1.00 | 2 | PO | Saline | Suspension |
Irwin, Rotarod | Ketoprofen | 1, 3, 6, 10 | 1.00 | 5 | PO | Saline | Solution |
Plantar incision, | Ketoprofen | 0.3, 1, 3, 6 | 1.00 | 5 | PO | Saline | Solution |
L5/L6 SNL | |||||||
Plantar incision | Morphine | 6 | 1.33 | 1 | SC | Saline | Solution |
L5/L6 SNL | Gabapentin | 60 | 1.00 | 1 | PO | Saline | Solution |
L5/L6 SNL = L5/L6 spinal nerve ligation; PO = per os; SC = subcutaneous
Results
Expand and Collapse accordion content
This work was conducted by PsychoGenics Inc. (Paramus, NJ) in collaboration with PSPP, NINDS, NIH under contract # 75N95019D00026. Prescribing information for clinically used controls can be found at labels.fda.gov. Information for icons representing experimental design details can be found through the NINDS Office of Research Quality https://go.nih.gov/Yw2tHGI.